Cephalexin Dosage Calculator for Dogs

How Cephalexin Works in Dogs: A Complete Guide

Cephalexin is a first-generation cephalosporin antibiotic that has been a cornerstone of small animal veterinary medicine for decades. It belongs to the beta-lactam class of antibiotics, which also includes penicillins, and works by interfering with bacterial cell wall synthesis. In dogs, cephalexin is most commonly prescribed for skin infections (pyoderma), urinary tract infections, wound infections, and soft tissue infections caused by susceptible bacteria. Understanding how cephalexin works, which bacteria it covers, and why the full course must always be completed is essential for every dog owner whose pet has been prescribed this medication.

Mechanism of Action: Cell Wall Disruption

Bacteria maintain their structural integrity through a rigid cell wall made of peptidoglycan, a mesh-like polymer of sugars and amino acids. For bacteria to grow and divide, they must continuously synthesize new peptidoglycan. This synthesis is carried out by a family of enzymes called penicillin-binding proteins (PBPs). Cephalexin works by covalently binding to PBPs and inhibiting their enzymatic activity. Without functional PBPs, bacteria cannot properly build or repair their cell walls. As the bacteria continue trying to grow and divide, structural weak points accumulate in the cell wall until it ruptures under osmotic pressure, killing the bacterium. This mechanism is classified as bactericidal, meaning cephalexin actively kills bacteria rather than merely slowing their growth. Bactericidal activity is particularly important for serious infections where the immune system may be compromised and the body needs the antibiotic to do most of the bacterial killing.

Antimicrobial Spectrum: What Cephalexin Covers and What It Does Not

First-generation cephalosporins like cephalexin have a spectrum of activity weighted toward gram-positive bacteria. In veterinary dermatology, this makes cephalexin an excellent choice for Staphylococcus pseudintermedius (the primary cause of canine pyoderma) and Streptococcus species. Among gram-negative organisms, cephalexin has useful activity against E. coli, Proteus mirabilis, and Klebsiella pneumoniae, which are common urinary tract pathogens in dogs. However, cephalexin has limited or no activity against several clinically important organisms. Pseudomonas aeruginosa, a gram-negative bacillus that commonly colonizes chronic or traumatized skin and ears, is inherently resistant to cephalexin. Enterococcus species, which occasionally cause UTIs in dogs, are also resistant. Methicillin-resistant Staphylococcus pseudintermedius (MRSP) and methicillin-resistant Staphylococcus aureus (MRSA) are resistant to all beta-lactam antibiotics including cephalexin, which is why culture and sensitivity testing before prescribing is critical for recurring or treatment-resistant infections. Starting cephalexin for a suspected infection that turns out to be MRSP delays appropriate treatment and potentially worsens the infection.

Pharmacokinetics: Absorption, Distribution, and Elimination

Cephalexin is well absorbed from the gastrointestinal tract after oral administration, with bioavailability in dogs of approximately 75 to 90 percent. Peak plasma concentrations occur approximately 1 to 2 hours after dosing. Food has minimal effect on the rate and extent of cephalexin absorption in dogs, which means it can be given with or without food, though giving it with food often helps dogs who experience mild nausea. Distribution of cephalexin throughout the body is moderate: it reaches good concentrations in skin, soft tissue, urine, and respiratory secretions. Penetration into bone is moderate, which is why osteomyelitis treatment requires higher doses and longer duration to achieve adequate concentrations at the infection site. Cephalexin does not penetrate well into the central nervous system and is not appropriate for CNS infections. Elimination is primarily renal (kidney), with approximately 80 to 90 percent of the drug excreted unchanged in the urine. This has two important implications: urine concentrations of cephalexin are very high, making it effective for lower urinary tract infections at moderate doses, but dogs with significant kidney disease will accumulate the drug and may require dose reduction or increased dosing intervals.

Why Dosing Frequency Matters: Time-Dependent Killing

Beta-lactam antibiotics including cephalexin demonstrate what pharmacologists call time-dependent killing. Unlike concentration-dependent antibiotics (such as aminoglycosides), where higher concentrations kill more bacteria, cephalexin kills bacteria at approximately the same rate regardless of whether the concentration is 2 times or 8 times the minimum inhibitory concentration (MIC) of the target organism. What matters for cephalexin efficacy is the percentage of time that the drug concentration at the infection site remains above the MIC of the pathogen. Studies indicate that beta-lactam antibiotics are most effective when tissue concentrations remain above the MIC for at least 40 to 50 percent of the dosing interval. For most susceptible canine pathogens, this requires dosing cephalexin every 8 to 12 hours. Owners who extend dosing intervals to once daily because a dog refuses medication or for convenience significantly compromise the drug’s effectiveness, even if the total daily dose is the same. This is one of the most common causes of antibiotic treatment failure in veterinary practice.

Skin Infections and Pyoderma: The Primary Veterinary Use

Canine pyoderma is one of the most common conditions treated in veterinary practice, and cephalexin is one of the most prescribed antibiotics for it. Superficial pyoderma involves the superficial layers of the skin and hair follicles and is characterized by pustules, epidermal collarettes, and crusting. It is almost universally caused by Staphylococcus pseudintermedius in dogs and is highly susceptible to cephalexin. Superficial pyoderma typically resolves with 7 to 14 days of cephalexin at 22 mg/kg twice daily. Deep pyoderma involves deeper skin layers and subcutaneous tissues, presenting as furunculosis (ruptured hair follicles), cellulitis, draining tracts, and sometimes deep nodular lesions. Deep pyoderma requires longer treatment at higher doses, often 22 to 30 mg/kg every 8 to 12 hours for 21 to 30 days or more, and culture and sensitivity testing is strongly recommended before starting treatment. A critical error in pyoderma management is stopping antibiotic treatment as soon as the skin looks normal, rather than completing the prescribed course. Pyoderma requires antibiotic treatment to continue for a minimum of 7 days beyond complete clinical resolution, because bacteria remain present in skin layers even after visible lesions resolve. Early cessation leads to relapse and the potential emergence of resistant strains.

Antibiotic Resistance and Responsible Use

Antibiotic resistance is one of the most serious challenges in both human and veterinary medicine. Staphylococcal resistance to first-generation cephalosporins has been increasing in companion animals, with methicillin-resistant Staphylococcus pseudintermedius (MRSP) now recognized globally. MRSP is resistant to all beta-lactam antibiotics and many other antibiotic classes, leaving few treatment options for affected dogs and potential zoonotic risk to human household members. The emergence of resistant strains is driven by antibiotic use, particularly by incomplete courses that expose bacteria to sub-therapeutic concentrations, by use of antibiotics when not needed (viral infections do not respond to antibiotics), and by use of inappropriate antibiotics when culture results indicate a different drug would be more effective. Responsible antibiotic stewardship in veterinary practice requires obtaining culture and sensitivity data for recurring or severe infections, selecting the narrowest-spectrum antibiotic that covers the likely pathogen, prescribing the correct dose and duration, and educating owners about the critical importance of course completion.

Drug Interactions and Special Populations

Cephalexin has relatively few significant drug interactions compared to many other antibiotics. Probenecid, a drug used in some human gout medications, reduces renal tubular secretion of cephalexin and can increase its plasma concentrations, which is rarely a concern in dogs but worth noting if a dog receives unusual medications. Concurrent use of nephrotoxic drugs (certain diuretics, NSAIDs at high doses, aminoglycoside antibiotics) with cephalexin in dogs with pre-existing kidney disease may increase the risk of nephrotoxicity. Dogs with penicillin allergy have a 1 to 2 percent cross-reactivity risk with cephalosporins; this is lower than historically cited but not negligible, and dogs with known severe penicillin hypersensitivity should receive cephalexin only under veterinary supervision with monitoring. Pregnant dogs may receive cephalexin when clinically necessary, as it is generally considered low risk in pregnancy, but the decision should be made by the treating veterinarian. Nursing dogs may also receive cephalexin, with small amounts appearing in milk, which is generally considered acceptable for nursing puppies.